ResearcherAsan Medical CenterActive in the last 2 years

InKi Kim

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5074553238. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper

Papers 1

Retraction: Downregulation of X-linked inhibitor of apoptosis protein by '7-Benzylidenenaltrexone maleate' sensitizes pancreatic cancer cells to TRAIL-induced … Last author DOI 10.18632/oncotarget.28813 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

So Young Kim · 1 shared paper, 2025 · strength 0.26
- Paper Retraction: Downregulation of X-linked inhibitor of apoptosis protein by '7-Benzylidenenaltrexone maleate' sensitizes p… DOI 10.18632/oncotarget.28813 ↗
Suhwan Chang · 1 shared paper, 2025 · strength 0.26
- Paper Retraction: Downregulation of X-linked inhibitor of apoptosis protein by '7-Benzylidenenaltrexone maleate' sensitizes p… DOI 10.18632/oncotarget.28813 ↗
Song Cheol Kim · 1 shared paper, 2025 · strength 0.26
- Paper Retraction: Downregulation of X-linked inhibitor of apoptosis protein by '7-Benzylidenenaltrexone maleate' sensitizes p… DOI 10.18632/oncotarget.28813 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.